🇺🇸
United States · US · US:54123-986_8c67e97f-118f-4226-972a-a9031ef6f5ce
Zubsolv
Orange BookUNIISPLATC N02AE
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerOrexo US, Inc.
CountryUS (United States)
ATC codeN02AE
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1154123986303 BLISTER PACK in 1 CARTON (54123-986-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Annotations
UNII (FDA Substance ID)
56W8MW3EN1
BUPRENORPHINE HYDROCHLORIDE
RxCUI 203841
Orange Book
N204242
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "56W8MW3EN1",
"rxcui": "203841",
"inchikey": "UAIXRPCCYXNJMQ-RZIPZOSSSA-N",
"display_name": "BUPRENORPHINE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBLINGUAL",
"spl_meta": {
"5f5cfcfe-d52b-49e6-8fe4-550477332dd2": {
"match": "brand_token",
"title": "ZUBSOLV (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE) TABLET, ORALLY DISINTEGRATING [OREXO US, INC.]",
"spl_version": "27",
"published_date": "2025-12-31"
}
},
"productid": "54123-986_8c67e97f-118f-4226-972a-a9031ef6f5ce",
"productndc": "54123-986",
"dosage_form": "TABLET, ORALLY DISINTEGRATING",
"orange_book": {
"appl_no": "204242",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 1.4MG BASE;EQ 0.36MG BASE",
"product_no": "001",
"approval_date": "Jul 3, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 5.7MG BASE;EQ 1.4MG BASE",
"product_no": "002",
"approval_date": "Jul 3, 2013"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 8.6MG BASE;EQ 2.1MG BASE",
"product_no": "003",
"approval_date": "Dec 11, 2014"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 11.4MG BASE;EQ 2.9MG BASE",
"product_no": "004",
"approval_date": "Dec 11, 2014"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 2.9MG BASE;EQ 0.71MG BASE",
"product_no": "005",
"approval_date": "Jun 4, 2015"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "EQ 0.7MG BASE;EQ 0.18MG BASE",
"product_no": "006",
"approval_date": "Oct 4, 2016"
}
],
"appl_type": "N"
},
"dea_schedule": "CIII",
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
"proprietary_name": "Zubsolv",
"active_ingred_unit": "mg/1; mg/1",
"application_number": "NDA204242",
"marketing_category": "NDA",
"nonproprietary_name": "buprenorphine hydrochloride and naloxone hydrochloride",
"start_marketing_date": "20141211",
"active_numerator_strength": "8.6; 2.1"
}Related drugs
Other records sharing ATC code N02AE.
- GBBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeViatris UK Healthcare Ltd
- GBBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeMartindale Pharmaceuticals Ltd
- GBBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeMedihealth (Northern) Ltd
- GBBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeAlliance Healthcare (Distribution) Ltd
- GBBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeDE Pharmaceuticals
- GBBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeA A H Pharmaceuticals Ltd
- GBBuprenorphine 8mg / Naloxone 2mg sublingual tablets sugar freeA A H Pharmaceuticals Ltd
- GBBuprenorphine 8mg / Naloxone 2mg sublingual tablets sugar freeMartindale Pharmaceuticals Ltd
Access this data programmatically
Query Zubsolv and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.